Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil H Shear

Showing results (181-190 of 192) with videos related to

Pageof 20
Sort By:
European Journal of Clinical Pharmacology|March 29, 2019
Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvementJennifer L Goldman, Wen-Hung Chung, Brian R Lee, et al.
Journal of Cutaneous Medicine and Surgery|November 9, 2016
Definition of Moderate to Severe Hidradenitis Suppurativa: A Position Paper by the Canadian Hidradenitis Suppurativa Foundation (CHSF)Afsaneh Alavi, David N Adam, Ra'ed Alhusayen, et al.
Cytokine|March 12, 2002
Serum tumour necrosis factor-alpha and transforming growth factor-beta levels in chronic hepatitis C patients are immunomodulated by therapyManuela G Neuman, Jean-Pierre Benhamou, Marc Bourliere, et al.
International Journal of Dermatology|December 27, 2018
Global perspectives for the management of onychomycosisAditya K Gupta, Rachel R Mays, Sarah G Versteeg, et al.
The Journal of Allergy and Clinical Immunology|December 22, 2018
Controversies in drug allergy: Testing for delayed reactionsElizabeth J Phillips, Paul Bigliardi, Andreas J Bircher, et al.
Journal of Cutaneous Medicine and Surgery|August 12, 2023
Baseline Characteristics of Canadian Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)Melinda J Gooderham, Robert Bissonnette, Sunil Kalia, et al.
JAMA Dermatology|March 16, 2017
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines: Results of a National Institutes of Health Working GroupEmanual Maverakis, Elizabeth A Wang, Kanade Shinkai, et al.
The Journal of Allergy and Clinical Immunology|October 15, 2020
Beta-lactam-induced immediate hypersensitivity reactions: A genome-wide association study of a deeply phenotyped cohortPaola Nicoletti, Daniel F Carr, Sarah Barrett, et al.
Clinical Pharmacology and Therapeutics|November 7, 2017
Research Directions in Genetic Predispositions to Stevens-Johnson Syndrome / Toxic Epidermal NecrolysisTeri A Manolio, Carolyn M Hutter, Mark Avigan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 10, 2018
SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and TranslationKatie D White, Riichiro Abe, Michael Ardern-Jones, et al.
Pageof 20

Showing results (181-190 of 192) with videos related to

Sort By:
Pageof 20
European Journal of Clinical Pharmacology|March 29, 2019
Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvementJennifer L Goldman, Wen-Hung Chung, Brian R Lee, et al.
Journal of Cutaneous Medicine and Surgery|November 9, 2016
Definition of Moderate to Severe Hidradenitis Suppurativa: A Position Paper by the Canadian Hidradenitis Suppurativa Foundation (CHSF)Afsaneh Alavi, David N Adam, Ra'ed Alhusayen, et al.
Cytokine|March 12, 2002
Serum tumour necrosis factor-alpha and transforming growth factor-beta levels in chronic hepatitis C patients are immunomodulated by therapyManuela G Neuman, Jean-Pierre Benhamou, Marc Bourliere, et al.
International Journal of Dermatology|December 27, 2018
Global perspectives for the management of onychomycosisAditya K Gupta, Rachel R Mays, Sarah G Versteeg, et al.
The Journal of Allergy and Clinical Immunology|December 22, 2018
Controversies in drug allergy: Testing for delayed reactionsElizabeth J Phillips, Paul Bigliardi, Andreas J Bircher, et al.
Journal of Cutaneous Medicine and Surgery|August 12, 2023
Baseline Characteristics of Canadian Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)Melinda J Gooderham, Robert Bissonnette, Sunil Kalia, et al.
JAMA Dermatology|March 16, 2017
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines: Results of a National Institutes of Health Working GroupEmanual Maverakis, Elizabeth A Wang, Kanade Shinkai, et al.
The Journal of Allergy and Clinical Immunology|October 15, 2020
Beta-lactam-induced immediate hypersensitivity reactions: A genome-wide association study of a deeply phenotyped cohortPaola Nicoletti, Daniel F Carr, Sarah Barrett, et al.
Clinical Pharmacology and Therapeutics|November 7, 2017
Research Directions in Genetic Predispositions to Stevens-Johnson Syndrome / Toxic Epidermal NecrolysisTeri A Manolio, Carolyn M Hutter, Mark Avigan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 10, 2018
SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and TranslationKatie D White, Riichiro Abe, Michael Ardern-Jones, et al.
Pageof 20